IRVINE, Calif. & TEL AVIV, Israel--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, and Ramot at Tel Aviv University Ltd., Tel Aviv University's technology transfer company, today announced a research collaboration and license agreement for a preclinical anti-beta amyloid small molecule product candidate for neuroprotection and dry age-related macular degeneration (dry AMD).
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
